Добро пожаловать
Зарегистрировать аккаунт
Войдите, используя email
Зарегистрируйтесь с помощью email
Проверь свои входящие
Boreal Genomics
About
Boreal develops research tools and diagnostic tests based on the monitoring of tumor mutations from cell-free DNA in plasma.
- 1 - 10
Details
- Last Funding Type
- Series C
- Last Funding Money Raised
- $18M
- Industries
- Biotechnology,Clinical Trials,Health Diagnostics
- Founded date
- Jan 1, 2007
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Boreal is committed to improving cancer patient care through the development of research tools and diagnostic tests based on the monitoring of tumor mutations from cell-free DNA in plasma. It also provides novel DNA enrichment and library construction solutions for high accuracy sequencing in liquid biopsy applications.The company's OnTarget platform performs highly sensitive mutation detection to enable accurate tumor profiling and real-time monitoring of tumor evolution from cell-free DNA in plasma. The OnTarget assay is available as a research-use service to reveal tumor mutations that are undetectable with other methods and may help guide selection of therapy, improve clinical trial efficiency, and accelerate drug development programs.Boreal Genomics was founded in 2007 and is based in Vancouver, BC, Canada.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Oct 4, 2013 | Series C | $18M | 1 | — | — | Detail |
Investments
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
ARCH Venture Partners
|
— | Series C |
